# A Randomized Controlled Trial of Sertraline in Paroxysmal Arterial Hypertension

Study · id `cardio:ct-nct02641652` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02641652](<https://clinicaltrials.gov/study/NCT02641652>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02641652

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 136 participants.

## Technical summary

Registry record NCT02641652. Randomized; quadruple masking; primary purpose treatment. Start 2017-11 (anticipated); primary completion 2018-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 136 participants (planned count; ClinicalTrials.gov record NCT02641652, source copy `cardio:ctgov-nct02641652-2017-09-08`, retrieved 2026-10-26)
- Planned start: 2017-11 (anticipated) (ClinicalTrials.gov record NCT02641652, source copy `cardio:ctgov-nct02641652-2017-09-08`, retrieved 2026-10-26)
- Primary completion: 2018-06 (anticipated) (ClinicalTrials.gov record NCT02641652, source copy `cardio:ctgov-nct02641652-2017-09-08`, retrieved 2026-10-26)
- Completion: 2018-12 (anticipated) (ClinicalTrials.gov record NCT02641652, source copy `cardio:ctgov-nct02641652-2017-09-08`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02641652-2017-09-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Randomized Controlled Trial of Sertraline in Paroxysmal Arterial Hypertension
- Acronym: ATRAX
- Condition: Hypertension
- Intervention (Drug): Sertraline
- Intervention (Drug): Placebo
- Lead sponsor: University Hospital Olomouc
- Lead sponsor class: OTHER
- Collaborator: Brno University Hospital
- Collaborator class: OTHER
- Collaborator: St. Anne
- Collaborator class: UNKNOWN
- Collaborator: University Hospital Ostrava
- Collaborator class: OTHER
- Collaborator: Tomas Bata Hospital, Czech Republic
- Collaborator class: OTHER
- Collaborator: Prerov Hospital
- Collaborator class: UNKNOWN
- Collaborator: Valasske Mezirici Hospital
- Collaborator class: UNKNOWN
- Collaborator: Thomayer University Hospital
- Collaborator class: OTHER
- Collaborator: Vsetin Hospital
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: University Hospital Olomouc (`cardio:org-university-hospital-olomouc`)
- Registry lists this organization as a collaborator: Brno University Hospital (`cardio:org-brno-university-hospital`)
- Registry lists this organization as a collaborator: University Hospital Ostrava (`cardio:org-university-hospital-ostrava`)

## Provenance

Content hash: b16dad58b206d518a1be576457f4a77e119aeda03c4f778909d3b7b8c936245c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
